Prostate Cancer Support Group - Richmond, Va


Meeting Dates - 3rd Thurs. each month - Time 7:00 PM - No July Meeting - The Dec. date will vary - Call for details - Peter C. Moon Phd. at 804-346-4407 between 7 - 11:00 PM - Location - Ridge Baptist Church, 1515 Eastridge Road Richmond, VA 23229

Vet

Rva Prostate Cancer Support Group

www.rvaprostatecancersupport.org
RVA

Articles Page

In good faith, this website was created to furnish you with helpful information. Nevertheless, no one who contributes or posts information to this website makes any guarantee regarding the information provided. Any decisions that you make regarding your health should be made in consultation with a qualified healthcare provider.


Affiliated with Us-TOO International Prostate Cancer Education & Support Network
Home Us Too International Other Support Groups Facts and Stats Emerging Treatments Contact Us Videos Complementary
Alternative Treatment Sources
Links Peter's Notes Flyer

*******************************************************************************************************
Articles on Informed Decision Making

Prostate Cancer
*******************************************************************************************************
Snuffy Myers On Immunotherapy For Prostate Cancer

Snuffy Myers On Immunotherapy For Prostate Cancer and other posts on the Prostatepedia Blog.

Click on Our Link to read all the posts
Blog
or go to:
https://www.prostatepedia.net/blogs/prostatepedia
*******************************************************************************************************
URO Today Articles of Interest

Active Surveillance: Protecting Patients From Harm
Optimizing Active Surveillance for Prostate Cancer
Magnetic Resonance Imaging-Targeted vs. Systematic Biopsies in Men on Active Surveillance: Results of a Prospective, Randomized Canadian Urology Research Consortium Trial.
Canadian Vs. U.S. Guidelines on Active Surveillance
A Systematic Approach to Discussing Active Surveillance with Patients with Low-risk Prostate Cancer: Beyond the Abstract
What ProtecT Tells Us About Active Surveillance - Session Highlights
Genomic Tests in Active Surveillance and the Role of Hereditary Testing - Session Highlights
Active Surveillance Patient Perspective Question and Answer Panel - Session Highlights
Statin Use and Time to Prostate Cancer Progression in Men Undergoing Active Surveillance
4th ESO Prostate Cancer Observatory: The Urologist’s Perspective on Active Surveillance
Association Between Germline Genetic Variation and Progression in Men with Low-Risk Prostate Cancer on Active Surveillance

Click on Our Link to read all the articles
(Use the search window to find the other articles - copy & paste the title in the window)
URO
or go to:
https://www.urotoday.com/conference-highlights/cua-2017/96650-cua-2017-optimizing-active-surveillance-for-prostate-cancer.html?utm_source=newsletter_5079&utm_medium=email&utm_campaign=optimizing-active-surveillance-for-prostate-cancer-highest-viewer-rated-content-in-2017
*******************************************************************************************************
Compare Prostate Cancer Treatments – High Risk
High Risk prostate cancer patients experience the highest range of results and approaches as they are likely to have prostate cancer outside of the prostate. When selecting a course of action, consultations are recommended with a urologist or surgeon, radiation oncologist and medical oncologist. Different treatments have different results and side effects. It is important to understand the potential impact each treatment can have on your quality of life after treatment.

The below link will give you an:
Interactive Comparison Graph - Compare Prostate Cancer Treatments - High Risk Group

Click on Our Link to read the article and use the graph
Graph
or go to:
http://www.pctrf.org/high-risk-results/
*******************************************************************************************************
Surgical Treatment of Male Postprostatectomy Incontinence: Current Concepts.
and
Diminished long-term recovery of peak flow rate (PFR) after robotic prostatectomy in men with baseline PFR <10 mL/s and incidental association with high-risk prostate cancer.

In October 2017, a nonsystematic review of the literature published within the last 2 yr was performed using the PubMed/Medline database. In total, 58 articles were included in the current analysis.
Click on Our Link to read all the articles
Current Concepts
or go to:
https://www.urotoday.com/index.php?option=com_content&view=category&id=1697&utm_source=newsletter_5078&utm_medium=email&utm_campaign=uroalerts-men-s-health-weekly
*******************************************************************************************************
Target definition in salvage postoperative radiotherapy for prostate cancer: 18F-fluorocholine PET/CT assessment of local recurrence.
Abstract:
PURPOSE: Inadequate clinical target volume (CTV) definition is likely to be a major contributing factor to local recurrence (LR) rate after radiotherapy. Our aims were to identify sites of prostate cancer LR in biochemical recurrence post-prostatectomy using 18F-Fluorocholine (18F-FCH) positron emission tomography/computed tomography (PET/CT) and to compare different CTV-delineation guidelines in a cohort of postoperative patients.
Click on Our Link to read more
PET/CT
or go to:
https://www.ncbi.nlm.nih.gov/pubmed/28984165
*******************************************************************************************************
August - Prostapedia from Dr. Myers:

"Aggressive Cancers"
In This Newsletter You will find:

In August, we’re talking about what used to be thought of as a rare form of metastatic prostate cancer but now appears to be quite common. In this month’s guest commentary, Dr. Neeraj Agarwal summarizes the problem of neuroendocrine cancer and frames the conversations that follow.

Click on Our Link to read more
Prostapedia
or go to:
http://rvaprostatecancersupport.org/PDF/Prostatepedia_August2017.pdf
*******************************************************************************************************
Article:

"Starving Cancer Cells" By a News Reporter-Staff News Editor at Cancer Weekly
On This Site You will find:

New research from The University of Texas at Austin identifies several natural compounds found in food, including turmeric, apple peels and red grapes, as key ingredients that could thwart the growth of prostate cancer, the most common cancer afflicting U.S. men.

Click on Our Link to read more
Starving
or go to:
http://www.ustoo.org/News-Page/oLV3sHZQWMQtc1carD3dty_0RDcajhv1Qg9LVIP9AQ_SZqyEJjil5giQ9b3kQcI9bzKzSd6kVVYf_79cXYtO3Q**
*******************************************************************************************************
Article:

"Mediterranean Herb Guards Vital Liver Functions" By Linda Nevis
On This Site You will find:

The liver performs over 500 life-sustaining functions, including neutralizing toxins.
Milk thistle, a plant native to the Mediterranean regions, has long been prized as a treatment for chronic liver ailments.
Human and animal studies are confirming these benefits.
Click on Our Link to read more
Milk thistle
or go to:
http://www.lifeextension.com/Magazine/2016/5/Mediterranean-Herb-Guards-Vital-Liver-Functions/Page-01
*******************************************************************************************************
Article:

Androgen Receptor Inhibitor - induced "BRCAness" and PARP inhibition
are synthetically lethal for castration-resistant prostate cancer.

On This Site You will find:

Cancers with loss-of-function mutations in BRCA1 or BRCA2 are deficient in the DNA damage repair pathway
called homologous recombination (HR), rendering these cancers exquisitely vulnerable to poly(ADP-ribose)
polymerase (PARP) inhibitors.

Click on Our Link to read more
Androgen Receptor Inhibitor
or go to:
https://www.urotoday.com/recent-abstracts/urologic-oncology/prostate-cancer/95995-androgen-receptor-inhibitor-induced-brcaness-and-parp-inhibition-are-synthetically-lethal-for-castration-resistant-prostate-cancer.html
*******************************************************************************************************
Article:

Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade.
On This Site You will find:

Prostate cancer (PCa) is the most common malignancy among Western men and the second leading-cause
of cancer related deaths. For men who develop metastatic castration resistant PCa (mCRPC), survival is
limited, making the identification of novel therapies for mCRPC critical.

Click on Our Link to read more
Lipid Catabolism
or go to:
https://www.urotoday.com/recent-abstracts/urologic-oncology/prostate-cancer/95534-lipid-catabolism-inhibition-sensitizes-prostate-cancer-cells-to-antiandrogen-blockade.html
*******************************************************************************************************
Article:

Advanced Prostate Cancer Consensus Conference: APCCC
On This Site You will find:

Articles - Video Lectures - Clinical Trials -Centers of Excellence - Conference Highlights - Journal - Calendar

Click on Our Link to read more
Conference
or go to:
https://www.urotoday.com/video-lectures/advanced-prostate-cancer-consensus-conference-apccc.html?utm_source=newsletter_4444&utm_medium=email&utm_campaign=advanced-prostate-cancer-consensus-conference-interviews-with-presenters-by-alicia-morgans-neal-shore-and-charles-ryan
*******************************************************************************************************
Article:

PCa Commentary Vol. #105: FOLLICLE STIMULATING HORMONE (FSH): Its Suppression by Degarelix (Firmagon)
May Contribute to the Drug’s Effectiveness in Androgen Suppression and Its Lesser Cardiotoxicity Compared to Leuprolide (Lupron.)

FOLLICLE STIMULATING HORMONE
or go to:
http://www.pctrf.org/pca-commentary-vol-105-follicle-stimulating-hormone-fsh-suppression-degarelix-firmagon-may-contribute-drugs-effectiveness-androgen-suppression-lesser-cardioto/
*******************************************************************************************************
Article:

Clinical comparison of the efficacy of three different bowel preparation methods on the infectious
complications following transrectal ultrasonography guided prostate biopsy in nursing practice.

Click on Our Link to read more
Infection
or go to:
https://www.ncbi.nlm.nih.gov/pubmed/28401738
*******************************************************************************************************
Article:

Dosimetric impacts of endorectal balloon in CyberKnife stereotactic body radiation therapy
(SBRT) for early-stage prostate cancer.

Click on Our Link to read more
CyberKnife
or go to:
https://www.ncbi.nlm.nih.gov/pubmed/28407345
*******************************************************************************************************
PAN Foundation

The copay assistance program for individuals with metastatic prostate cancer has just opened at the Patient
Access Network (PAN) Foundation. This is a great potential opportunity for eligible men affected by metastatic
prostate cancer to receive up to $12,000 a year in financial assistance.

For more information visit:

Click on Our Link to read more

PAN

or go to:
http://bit.ly/2n1SftA

You may apply online or call 1-866-316-7263.

****************************************************************************************************

Article:

Two-thirds of Americans see docs who got paid by drug companies: Study
Drexel University Health News, 03/16/2017

About 65 percent of those surveyed as a part of the study by Genevieve Pham–Kanter, PhD, an assistant professor
in Drexel’s Dornsife School of Public Health, visited a doctor within the last year who had received payments or
gifts from pharmaceutical or medical device companies. What’s more: Only 5 percent of those surveyed knew that their
doctor had received such payments.

Click on Our Link to read more

Article

or go to:
https://www.mdlinx.com/family-medicine/medical-news-article/2017/03/16/doctors-payments-from-drug-companies/7087462/

****************
Has Your Doctor Received Drug or Device Company Money?

Click on Our Link to find out

Money

or go to:
https://www.mdlinx.com/family-medicine/news.cfm

*******************************************************************************************************
What It’s Like to Be Part of a Prostate Cancer Support Group

Advocacy - We speak with two specialists from a prostate cancer support group about the ways this
experience empowers men and their loved ones.

Stigma continues to surround men’s health in general, and prostate health in particular.
Having a support network, however, can help to curb these threats. Terri Likowski and Ken Wilmarth
from Us TOO’s support group open up about the ways an organization like theirs can give
members a bedrock of information — and hope.

Click on Our Link to read more

Support Group

or go to:
http://www.futureofpersonalhealth.com/advocacy/what-its-like-to-be-part-of-a-prostate-cancer-support-group

*********************************

Scientists use new 'blood biopsies' with experimental device to speed
cancer diagnosis and predict disease spread.


Researchers are using a new blood-analysis technique and tiny experimental device to help physicians predict
which cancers are likely to spread by identifying and characterizing tumor cells circulating through the blood.

Click on Our Link to read more

Blood Biopsies

or go to:
https://www.sciencedaily.com/releases/2017/02/170213091131.htm

*********************************

Life Extension Magazine

How to Reverse Markers of Prostate Cancer.

Despite prostate cancer being the second leading cause of cancer death in men, a raging debate has ensued as
to whether men should have annual PSA blood tests. The scales are tilting in favor of Life Extension®’s
multi-decade campaign to educate men about the importance of regular PSA screening. Not only are there proven
ways to reverse rising PSA levels, but breakthrough treatments can enable safer diagnosis and curative treatment
without the side effects associated with conventional surgery and radiation.

To Read The Articles - Click on Our Link

Life Extension Magazine

or go to:

http://www.lifeextension.com/Magazine/2016/6

*******************************************************************************************************
URO Today
Your Urology News and Education Resource.

Here you will find Articles, Videos Lectures, Clinical Trials and more. All are Choice topics on Immunotherapy.
Look Around the site & find the Topic that suits your needs by clicking on their links.

UroToday always offers free, open access to all site content - Enter your email address to sign in and
they will send you an Email link to sign in with.

To Read The Articles - Click on Our Link

URO Today

or go to:

https://www.urotoday.com/

**********************************************************************************

Meeting Information for Dec 8 2016

After the Us Too dinner on 12/8/2016 there will be a discussion on
"Preventing PCa Metastasis by Blocking MMPs

To get up to speed - Read the below - Click on Our Link

MMPs

or go to

href="http://www.jamersonscrafts.com/Pictures/PDF/Prevent PCa Metastasis by Blocking MMPs.pdf

************************************************

Meeting Handout for Nov 17 2016

Us Too Warriors, We hope you can come to the meeting and bring
a copy of the handout covering ADT and its Possible Problems:

Cognitive – Depression, Stress, Alzheimer’s, Parkinson’s increase, Headache
Metabolic- Weight gain, Muscle mass loss, Fat mass up, Lipids LDL +/HDL -, TriGly. +, Diabetes
Physical- Fatigue, Muscle weakness, Falls, BMD -, Fractures, B. +, Sex organs –, ED, Hot Flashes
Heart - Heart disease ~+20 to 40 % if already precent, Diabetes, Insulin resistance.



To Read and print this Handout - Click on Our Link

Handout

or go to
href="http://www.jamersonscrafts.com/Pictures/PDF/Us Too Warriors Nov17 2016.pdf